FAM120A | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
macrophage	28 studies	24% ± 11%	Explore
endothelial cell	24 studies	28% ± 11%	Explore
classical monocyte	19 studies	28% ± 12%	Explore
ciliated cell	17 studies	32% ± 14%	Explore
monocyte	15 studies	23% ± 6%	Explore
non-classical monocyte	14 studies	24% ± 11%	Explore
fibroblast	14 studies	22% ± 7%	Explore
astrocyte	12 studies	31% ± 15%	Explore
pericyte	11 studies	21% ± 9%	Explore
microglial cell	11 studies	33% ± 13%	Explore
glutamatergic neuron	10 studies	39% ± 27%	Explore
oligodendrocyte precursor cell	10 studies	29% ± 14%	Explore
oligodendrocyte	10 studies	28% ± 10%	Explore
goblet cell	9 studies	32% ± 14%	Explore
epithelial cell	9 studies	43% ± 19%	Explore
type I pneumocyte	8 studies	25% ± 8%	Explore
basal cell	8 studies	33% ± 16%	Explore
conventional dendritic cell	8 studies	30% ± 17%	Explore
myeloid cell	8 studies	32% ± 15%	Explore
endothelial cell of lymphatic vessel	7 studies	25% ± 9%	Explore
club cell	7 studies	29% ± 10%	Explore
B cell	7 studies	20% ± 4%	Explore
dendritic cell	7 studies	31% ± 17%	Explore
capillary endothelial cell	6 studies	18% ± 4%	Explore
transit amplifying cell	6 studies	33% ± 20%	Explore
adipocyte	6 studies	21% ± 4%	Explore
smooth muscle cell	6 studies	20% ± 2%	Explore
respiratory goblet cell	5 studies	26% ± 7%	Explore
secretory cell	5 studies	20% ± 4%	Explore
neuron	5 studies	35% ± 17%	Explore
endothelial cell of artery	5 studies	18% ± 2%	Explore
interneuron	5 studies	38% ± 23%	Explore
vein endothelial cell	5 studies	24% ± 13%	Explore
hepatocyte	5 studies	39% ± 22%	Explore
type II pneumocyte	5 studies	28% ± 10%	Explore
GABAergic neuron	5 studies	46% ± 22%	Explore
natural killer cell	5 studies	19% ± 2%	Explore
alveolar macrophage	5 studies	27% ± 11%	Explore
ionocyte	4 studies	25% ± 7%	Explore
hematopoietic precursor cell	4 studies	29% ± 9%	Explore
granule cell	4 studies	21% ± 4%	Explore
progenitor cell	4 studies	23% ± 4%	Explore
mucus secreting cell	4 studies	24% ± 5%	Explore
cardiac muscle cell	4 studies	20% ± 3%	Explore
mononuclear phagocyte	4 studies	26% ± 7%	Explore
lymphocyte	4 studies	30% ± 8%	Explore
plasmacytoid dendritic cell	4 studies	20% ± 4%	Explore
CD16-negative, CD56-bright natural killer cell, human	3 studies	16% ± 1%	Explore
CD4-positive, alpha-beta T cell	3 studies	17% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	17% ± 1%	Explore
glomerular endothelial cell	3 studies	18% ± 3%	Explore
intestinal crypt stem cell	3 studies	31% ± 12%	Explore
brush cell	3 studies	30% ± 19%	Explore
retinal cone cell	3 studies	23% ± 4%	Explore
serous secreting cell	3 studies	20% ± 4%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	3 studies	23% ± 11%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	19% ± 4%	Explore
CD8-positive, alpha-beta T cell	3 studies	18% ± 3%	Explore
enteroendocrine cell	3 studies	25% ± 6%	Explore
leukocyte	3 studies	28% ± 1%	Explore
neutrophil	3 studies	18% ± 1%	Explore
erythroblast	3 studies	40% ± 18%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	15 studies	32% ± 20%	Explore
lung	10 studies	26% ± 11%	Explore
liver	6 studies	26% ± 12%	Explore
intestine	5 studies	20% ± 4%	Explore
peripheral blood	3 studies	33% ± 3%	Explore
placenta	3 studies	27% ± 10%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	8411.17	459 / 459	100%	135.71	1118 / 1118
esophagus	100%	8752.26	1445 / 1445	100%	180.19	183 / 183
intestine	100%	10880.94	966 / 966	100%	133.99	527 / 527
lung	100%	9295.57	578 / 578	100%	109.27	1155 / 1155
prostate	100%	8278.66	245 / 245	100%	108.84	502 / 502
stomach	100%	7966.33	359 / 359	100%	146.08	286 / 286
thymus	100%	8850.99	653 / 653	100%	88.22	604 / 605
liver	100%	6188.21	226 / 226	100%	55.65	405 / 406
bladder	100%	10108.86	21 / 21	100%	93.17	502 / 504
pancreas	100%	6369.83	328 / 328	99%	96.12	177 / 178
uterus	100%	8738.60	170 / 170	99%	88.98	456 / 459
ovary	100%	7880.14	180 / 180	99%	84.04	427 / 430
kidney	100%	6742.70	89 / 89	99%	82.76	894 / 901
brain	99%	4720.23	2621 / 2642	100%	64.13	705 / 705
skin	100%	9890.97	1809 / 1809	98%	78.63	464 / 472
adrenal gland	100%	11109.64	258 / 258	97%	60.15	224 / 230
adipose	100%	9057.30	1204 / 1204	0%	0	0 / 0
blood vessel	100%	8293.25	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	76.64	29 / 29
muscle	100%	9350.26	803 / 803	0%	0	0 / 0
spleen	100%	8731.23	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	97.28	45 / 45
ureter	0%	0	0 / 0	100%	61.25	1 / 1
heart	98%	6457.15	840 / 861	0%	0	0 / 0
peripheral blood	96%	6774.76	888 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	94%	65.73	75 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0005829	Cellular component	cytosol
GO_0005886	Cellular component	plasma membrane
GO_0016020	Cellular component	membrane
GO_0005634	Cellular component	nucleus
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	FAM120A
Protein name	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated SRC activator) (Protein FAM120A) Family with sequence similarity 120A
Synonyms	KIAA0183 OSSA C9orf10
Description	FUNCTION: Component of the oxidative stress-induced survival signaling. May regulate the activation of SRC family protein kinases . May act as a scaffolding protein enabling SRC family protein kinases to phosphorylate and activate PI3-kinase . Binds IGF2 RNA and promotes the production of IGF2 protein . .
Accessions	Q9NZB2 ENST00000446420.2 A0A8V8TNY3 A0A0C4DG79 ENST00000698944.1 ENST00000375389.7 [Q9NZB2-2] ENST00000277165.11 [Q9NZB2-1] A0A0C4DH52 ENST00000652239.1 A0A494C0Y9 ENST00000427765.1

FAM120A report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review